Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3730106012 | Canakinumab only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3730107015 | Product containing only canakinumab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 2827091000001115 | Canakinumab (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2827101000001114 | Canakinumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Canakinumab | Is a | Product containing canakinumab | true | Inferred relationship | Existential restriction modifier | ||
| Canakinumab | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Canakinumab | Has active ingredient | Canakinumab | true | Inferred relationship | Existential restriction modifier | 1 | |
| Canakinumab | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only canakinumab in parenteral dose form (medicinal product form) | Is a | True | Canakinumab | Inferred relationship | Existential restriction modifier | |
| Canakinumab 150mg powder for solution for injection vials | Is a | True | Canakinumab | Inferred relationship | Existential restriction modifier | |
| Canakinumab 150mg/1ml solution for injection vials | Is a | True | Canakinumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR